3-(2-Amino-propyl)-5-brom-indol | 945-17-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(2-Amino-propyl)-5-brom-indol
• 英文别名: 5-Brom-α-methyl-tryptamin；5-Brom-3-(2-amino-propyl)-indol；2-(5-bromo-indol-3-yl)-1-methyl-ethylamine；1-(5-bromo-1H-indol-3-yl)propan-2-amine
• CAS: 945-17-5
• 化学式: C₁₁H₁₃BrN₂
• 分子量: 253.142
• InChiKey: IGHWRFCBYBVCLC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  41.8
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 3-(2-Amino-propyl)-5-brom-indol 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 2.0h， 生成
  参考文献：
  名称：

  Synthesis and structure–activity relationship of novel conformationally restricted analogues of serotonin as 5-HT₆ receptor ligands

  摘要：

  5-Hydroxytryptamine 6 receptors (5-HT6R) are being perceived as the possible target for treatment of cognitive disorders as well as obesity. The present article deals with the design, synthesis, in vitro binding and structure-activity relationship of a novel series of tetracyclic tryptamines with the rigidized N-arylsulphonyl, N-arylcarbonyl and N-benzyl substituents as 5-HT6 receptor ligands. The chiral sulphonyl derivatives 15a and 17a showed high affinity at 5-HT6R with the K-i of 23.4 and 20.5 nM, respectively. The lead compound from the series 15a has acceptable ADME properties, adequate brain penetration and is active in animal models of cognition like Novel Object Recognition Task (NORT) and water maze.

  DOI：

  10.3109/14756366.2011.595713
• 作为产物：
  描述：

  5-溴吲哚-3-甲醛 在 哌啶 、 lithium aluminium tetrahydride 、 溶剂黄146 作用下， 以 四氢呋喃 、 苯 为溶剂， 生成 3-(2-Amino-propyl)-5-brom-indol
  参考文献：
  名称：

  Synthesis and structure–activity relationship of novel conformationally restricted analogues of serotonin as 5-HT₆ receptor ligands

  摘要：

  5-Hydroxytryptamine 6 receptors (5-HT6R) are being perceived as the possible target for treatment of cognitive disorders as well as obesity. The present article deals with the design, synthesis, in vitro binding and structure-activity relationship of a novel series of tetracyclic tryptamines with the rigidized N-arylsulphonyl, N-arylcarbonyl and N-benzyl substituents as 5-HT6 receptor ligands. The chiral sulphonyl derivatives 15a and 17a showed high affinity at 5-HT6R with the K-i of 23.4 and 20.5 nM, respectively. The lead compound from the series 15a has acceptable ADME properties, adequate brain penetration and is active in animal models of cognition like Novel Object Recognition Task (NORT) and water maze.

  DOI：

  10.3109/14756366.2011.595713

文献信息

• Indolderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
  申请人：Dr. Karl Thomae GmbH

  公开号：EP0146787A2

  公开（公告）日：1985-07-03

  Die vorliegende Erfindung betrifft neue Indolderivate der allgemeinen Formel In der A eine oder und B eine Methylen-, Carbonyl- oder Thiocarbonylgruppe oder A eine Methylengruppe, E eine Alkylengruppe, eine 2-Hydroxy-n-propylen-, 2-Hydroxy-n-butylen- oder 3-Hydroxy-n-butylengruppe, G eine Alkylengruppe, R1 ein Wasserstoff-, Chlor- oder Bromatom, eine Trifluormethyl-, Nitro-, Amino-, Alkylamino-, Dialkylamino-, Alkyl-, Hydroxy-, Alkoxy- oder Phenylalkoxygruppe, R2 ein Wasserstoff-, Chlor- oder Bromatom, eine Hydroxy-, Alkoxy-, Phenylalkoxy- oder Alkylgruppe oder R1 und R2 zusammen eine Alkylendioxygruppe, R3 ein Wasserstoff-, Chlor- oder Bromatom oder eine Alkylgruppe, R4 ein Wasserstoffatom, eine Alkyl- oder Phenylalkylgruppe, R5 ein Wasserstoff-, Fluor-, Chlor- oder Bromatom, eine Alkyl-, Hydroxy-, Alkoxy- oder Phenylalkoxygruppe, R6 ein Wasserstoffatom oder eine Alkoxygruppe und R7 ein Wasserstoffatom, eine Alkoxygruppe, eine Alkyl- oder Phenylalkylgruppe bedeuten, und deren Säureadditionssalze, welche wervolle pharmakologische Eigenschaften aufweisen, insbesondere eine herzfrequenzsenkende Wirkung. Die neuen Verbindungen können nach an sich bekannten Verfahren hergestellt werden.

  本发明涉及通式如下的新型吲哚衍生物 其中 A 是 或 和 B 是亚甲基、羰基或硫代羰基或 A 是一个 亚甲基、 E 是亚烷基、2-羟基-正丙烯、2-羟基-正丁烯或 3-羟基-正丁烯基团，G 是亚烷基、 R1 是氢、氯或溴原子、三氟甲基、硝基、氨基、烷基氨基、二烷基氨基、烷基、羟基、烷氧基或苯基烷氧基、 R2 是氢、氯或溴原子，羟基、烷氧基、苯基烷氧基或烷基，或 R1 和 R2 共同形成一个亚烷基二氧基基团、 R3 是氢、氯或溴原子或烷基、 R4 是氢原子、烷基或苯基烷基，R5 是氢、氟、氯或溴原子、烷基、羟基、烷氧基或苯基烷氧基、 R6 是氢原子或烷氧基，以及 R7 是氢原子、烷氧基、烷基或苯基烷基，以及它们的酸加成盐，具有重要的药理特性，尤其是降低心率的作用。 这些新化合物可以通过已知的方法生产。
• PROCESSES FOR THE PRODUCTION OF TRYPTAMINES
  申请人：New Atlas Biotechnologies LLC

  公开号：EP3762498A1

  公开（公告）日：2021-01-13
• US4616011A
  申请人：——

  公开号：US4616011A

  公开（公告）日：1986-10-07
• [EN] PROCESSES FOR THE PRODUCTION OF TRYPTAMINES<br/>[FR] PROCÉDÉ DE PRODUCTION DE TRYPTAMINES
  申请人：NEW ATLAS BIOTECHNOLOGIES LLC

  公开号：WO2019173797A1

  公开（公告）日：2019-09-12

  Disclosed herein are prokaryotic and eukaryotic microbes, including E. coli and S. cerevisiae, genetically altered to biosynthesize tryptamine and tryptamine derivatives. The microbes of the disclosure may be engineered to contain plasmids and stable gene integrations containing sufficient genetic information for conversion of an anthranilate or an indole to a tryptamine. The fermentative production of substituted tryptamines in a whole-cell biocatalyst may be useful for cost effective production of these compounds for therapeutic use.
• Synthesis and structure–activity relationship of novel conformationally restricted analogues of serotonin as 5-HT₆ receptor ligands
  作者：Ramakrishna V.S. Nirogi、Ramasastri Kambhampati、Prabhakar Kothmirkar、Jagadishbabu Konda、Thrinath Reddy Bandyala、Parandhama Gudla、Sobhanadri Arepalli、Narasimhareddy P. Gangadasari、Anil K. Shinde、Amol D. Deshpande、Adireddy Dwarampudi、Anil K. Chindhe、Pramod Kumar Dubey

  DOI：10.3109/14756366.2011.595713

  日期：2012.6.1

  5-Hydroxytryptamine 6 receptors (5-HT6R) are being perceived as the possible target for treatment of cognitive disorders as well as obesity. The present article deals with the design, synthesis, in vitro binding and structure-activity relationship of a novel series of tetracyclic tryptamines with the rigidized N-arylsulphonyl, N-arylcarbonyl and N-benzyl substituents as 5-HT6 receptor ligands. The chiral sulphonyl derivatives 15a and 17a showed high affinity at 5-HT6R with the K-i of 23.4 and 20.5 nM, respectively. The lead compound from the series 15a has acceptable ADME properties, adequate brain penetration and is active in animal models of cognition like Novel Object Recognition Task (NORT) and water maze.